Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease

Pediatric Endocrinology Reviews

Volumn 3, Issue 3, 2006, Pages 249-257

  Domènech, Enric ^a   Gómez Zaera, Montse ^a   Nunes, Virginia ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

DIDMOAD; Mitochondria DNA; Mutations; WFS1; Wolfram syndrome

Indexed keywords

FURIN; MEMBRANE PROTEIN; MITOCHONDRIAL DNA; UNCLASSIFIED DRUG; WFS1 PROTEIN;

AUTOSOMAL RECESSIVE DISORDER; CALCIUM HOMEOSTASIS; CHROMOSOME 4P; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIABETES INSIPIDUS; DIABETES MELLITUS; GENE; HEARING IMPAIRMENT; HUMAN; HYPOGONADISM; INSULIN DEPENDENT DIABETES MELLITUS; MENTAL DISEASE; NEUROGENIC BLADDER; ONSET AGE; OPTIC NERVE ATROPHY; REVIEW; WFS1 GENE; WOLFRAM SYNDROME;

ADOLESCENT; CALCIUM; CHILD; CHROMOSOMES, HUMAN, PAIR 4; DNA, MITOCHONDRIAL; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMANS; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; WOLFRAM SYNDROME;

EID: 33645395576     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Page MM, Asmal AC, Edwards CR. Recessive inheritance of diabetes: the syndrome of diabetes insipidus, diabetes mellitus, optic atrophy and deafness. Q J Med 1976;45:505-520
2. Cremers CW, Wijdeveld PG, Pinckers AJ. Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome). A review of 88 cases from the literature with personal observations on 3 new patients. Acta Paediatr Scand Suppl 1977;1-16
3. Fraser FC, Gunn T. Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome? J Med Genet 1977;14:190-193
4. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458-1463
5. von Graefe A. Ubed die mit diabetes vorkommenden shstorunger. Archiv für Ophthalmologie 1858;4:201
6. Wolfram D, Wagener H. Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin. Proc 1938;13:715-718
7. Rose FC, Fraser GR, Friedmann AI, Kohner EM. The association of juvenile diabetes mellitus and optic atrophy: clinical and genetical aspects. Q J Med 1966;35:385-405
8. Paley RG, Tunbridge RE. Primary optic atrophy in diabetes mellitus. Diabetes 1956;5:295-296
9. Pilley SF, Thompson HS. Familial syndrome of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (didmoad) in childhood. Br J Ophthalmol 1976;60:294-298
10. Bundey S, Poulton K, Whitwell H, Curtis E, Brown IA, Fielder AR. Mitochondrial abnormalities in the DIDMOAD syndrome. J Inherit Metab Dis 1992;15:315-319
11. Rotig A, Cormier V, Chatelain P, Francois R, Saudubray JM, Rustin P, Munnich A. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy and deafness (DIDMOAD, Wolfram syndrome). J Inherit Metab Dis 1993;16:527-530
12. Rotig A, Cormier V, Chatelain P, Francois R, Saudubray JM, Rustin P, Munnich A. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Gin Invest 1993;91:1095-1098
13. Polymeropoulos MH, Swift RG, Swift M. Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet 1994;8:95-97
14. Barrientos A, Casademont J, Saiz A, Cardellach F, Volpini V, Solans A, Tolosa E, Urbano-Marquez A, Estivill X, Nunes V. Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am J Hum Genet 1996;58:963-970
15. Barrientos A, Volpini V, Casademont J, Genis D, Manzanares JM, Ferrer I, Corral J, Cardellach F, Urbano-Marquez A, Estivill X, Nunes V. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest 1996;97:1570-1576
16. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E, Mueckler M, Marshall H, Donis-Keller H, Crock P, Racers D, Mikuni M, Kumashiro H, Higashi K, Sobue G, Oka Y, Permutt MA. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998;20:143-148
17. Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, Rabl W, Gerbitz KD, Meitinger T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998;7:2021-2028
18. Bespalova IN, Van Camp G, Bom SJ, Brown DJ, Cryns K, DeWan AT, Erson AE, Flothmann K, Kunst HP, Kurnool P, Sivakumaran TA, Cremers CW, Leal SM, Burmeister M, Lesperance MM. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 2001;10:2501-2508
19. Voung TL, Ives E, Lynch E, Person R, Snook S, MacLaren L, Cater T, Griffin A, Fernandez B, Lee MK, King MC. Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. Hum Mol Genet 2001;10:2509-2514
20. Cryns K, Pfister M, Pennings RJ, Bom SJ, Flothmann K, Caethoven G, Kremer H, Schatteman I, Koln KA, Toth T, Kupka S, Blin N, Nurnberg P, Thiele H, van de Heyning PH, Reardon W, Stephens O, Cremers CW, Smith RJ, Van Camp G. Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations. Hum Genet 2002;110:389-394
21. Cryns K, Sivakumaran TA, Van den Ouweland JM, Pennings RJ, Cremers CW, Flothmann K, Voung TL, Smith RJ, Lesperance MM, Van Camp G. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat 2003;22:275-287
22. Cryns K, Thys S, Van Laer L, Oka Y, Pfister M, Van Nassauw L, Smith RJ, Timmermans JP, Van Camp G. The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells. Histochem Cell Biol 2003;119:247-256
23. Lesperance MM, Hall JW, 3rd, San Agustin TB, Leal SM. Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2003;129:411-420
24. Penninss RJ, Bom SJ, Cryns K, Flothmann K, Huygen PL, Kremer H, Van Camp G, Cremers CW. Progression of low-frequency sensorineural hearing loss (DFNA6/14-WFS1). Arch Otolaryngol Head Neck Surg 2003;129:421-426
25. Pennings RJ, Cryns K, Huygen PL, van Camp G, Cremers CW. [From gene to disease; non-syndromic, autosomal dominant, low-frequency sensorineural hearing loss (DFNA6/14)]. Ned Tijdschr Geneeskd 2003;147:2170-2172
26. El-Shanti H, Lidral AC, Jarrah N, Druhan L, Ajlouni K. Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am J Hum Genet 2000;66:1229-1236
27. Khanim F, Kirk J, Latif F, Barrett TG. WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat 2001;17:357-367
28. Richardson JE, Hamilton W. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. 3 cases of 'DIDMOAD' syndrome. Arch Dis Child 1977;52:796-798
29. Khardori R, Stephens JW, Page OC, Dow RS. Diabetes mellitus and optic atrophy in two siblings: a report on a new association and a review of the literature. Diabetes Care 1983;6:67-70
30. Swift RC, Sadler DB, Swift M. Psychiatric findings in Wolfram syndrome homozygotes. Lancet 1990;336:667-669
31. Simsek E, Simsek T, Tekgul S, Hosal S, Seyrantepe V, Aktan G. Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of the literature. Acta Paediatr 2003;92:55-61
32. Monson JP, Boucher BJ. HLA type and islet cell antibody status in family with (diabetes insipidus and mellitus, optic atrophy, and deafness) DIDMOAD syndrome. Lancet 1983;1:1286-1287
33. Stanley CA, Spielman RS, Zmijewski CM, Baker L. Wolfram syndrome not HLA linked. N Engl J Med 1979;301:1398-1399
34. Karasik A, O'Hara C, Srikanta S, Swift M, Soeldner JS, Kahn CR, Herskowitz RD. Genetically programmed selective islet beta-cell loss in diabetic subjects with Wolfram's syndrome. Diabetes Care 1989;12:135-138
35. Ishihara H, Takeda S, Tamura A, Takahashi R, Yamaguchi S, Takei D, Yamada T, Inoue H, Soga H, Katagiri H, Tanizawa Y, Oka Y. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 2004;13:1159-1170
36. McBain SC, Morgan NG. Functional effects of expression of wolframin-antisense transcripts in BRIN-BD11 beta-cells. Biochem Biophys Res Commun 2003;307:684-688
37. Garcia-Luna PP, Villechenous E, Leal-Cerro A, Duran S, Jorge S, Wichmann I, Nunez-Roldan A, Astorga R. Contrasting features of insulin dependent diabetes mellitus associated with neuroectodermal defects and classical insulin dependent diabetes mellitus. Acta Paediatr Scand 1988;77:413-418
38. Minton JA, Rainbow LA, Ricketts C, Barrett TG. Wolfram syndrome. Rev Endocr Metab Disord 2003;4:53-59
39. Eller P, Foger B, Gander R, Souper T, Lechleitner M, Finkenstedt G, Patsch JR. Wolfram syndrome: a clinical and molecular genetic analysis. J Med Genet 2001;38:E37
40. Ajlouni K, Jarrah N, El-Khateeb M, El-Zaheri M, El Shanti H, Lidral A. Wolfram syndrome: identification of a phenotypic and genotypic variant from Jordan. Am J Med Genet 2002;115:61-65
41. Medlej R, Wasson J, Baz P, Azar S, Salti I, Loiselet J, Permutt A, Halaby G. Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab 2004;89:1656-1661
42. Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997;34:838-841
43. Barrett TG, Bundey SE, Fielder AR, Good PA. Optic atrophy in Wolfram (DIDMOAD) syndrome. Eye 1997;11 (Pt 6):882-888
44. Al-Till M, Jarrah NS, Ajlouni KM. Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophthalmol 2002;12:84-88
45. Smith CJ, Crock PA, King BR, Meldrum CJ, Scott RJ. Phenotype-genotype correlations in a series of wolfram syndrome families. Diabetes Care 2004;27:2003-2009
46. Dedes W, Wildberger H, Landau K. Optic atrophy as a sign of Wolfram syndrome. Klin Monatsbl Augenheilkd 2005;222:248-251
47. Thompson CJ, Charlton J, Walford S, Baird J, Hearnshaw J, McCulloch A, Kelly W, Baylis PH. Vasopressin secretion in the DIDMOAD (Wolfram) syndrome. Q J Med 1989;71:333-345
48. Gabreeis BA, Swaab DF, de Kleijn DP, Dean A, Seidah NG, Van de Loo JW, Van de Ven WJ, Martens GJ, Van Leeuwen FW. The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2. J Clin Endocrinol Metab 1998;83:4026-4033
49. Pennings RJ, Huygen PL, von den Ouweland JM, Cryns K, Dikkeschei LD, Van Camp G, Cremers CW. Sex-related hearing impairment in Wolfram syndrome patients identified by inactivating WFS1 mutations. Audiol Neurootol 2004;9:51-62
50. Scolding NJ, Kellar-Wood HF, Shaw C, Shneerson JM, Antoun N. Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol 1996;39:352-360
51. Shannon P, Becker L, Deck J. Evidence of widespread axonal pathology in Wolfram syndrome. Acta Neuropathol (Berl) 1999;98:304-308
52. Gomez-Zaera M, Strom TM, Rodriguez B, Estivill X, Meitinger T, Nunes V. Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol Genet Metab 2001;72:72-81
53. Domenech E, Gomez-Zaera M, Nunes V. Study of the WFS1 gene and mitochondrial DNA in Spanish Wolfram syndrome families. Clin Genet 2004;65:463-469
54. Colosimo A, Guida V, Rigoli L, Di Bella C, De Luca A, Briuglia S, Stuppia L, Salpietro DC, Dallapiccola B. Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum Mutat 2003;21:622-629
55. Davidson IR, McNicholl JM, O'Donnell J. Successful pregnancy in two sisters with Wolfram syndrome. Ir Med J 1993;86:33-34
56. Wilson JD, Moore G. Successful pregnancy in the DIDMOAD syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, deafness). Aust N Z J Obstet Gynaecol 1995;35:100-101
57. Rugolo S, Mirabella D, Palumbo MA, Chiantello R, Fiore G. Complete Wolfram's syndrome and successful pregnancy. Eur J Obstet Gynecol Reprod Biol 2002;105:192-193
58. Swift RG, Perkins DO, Chase CL, Sadler DB, Swift M. Psychiatric disorders in 36 families with Wolfram syndrome. Am J Psychiatry 1991;148:775-779
59. Swift RG, Polymeropoulos MH, Torres R, Swift M. Predisposition of Wolfram syndrome heterozygotes to psychiatric illness. Mol Psychiatry 1998;3:86-91
60. Gurtler N, Kim Y, Mhatre A, Schlegel C, Mathis A, Lalwani AK. DFNA54, a third locus for low-frequency hearing loss. J Mol Med 2004;82:775-780
61. Gurtler N, Kim Y, Mhatre A, Schlegel C, Mathis A, Daniels R, Shelton C, Lalwani AK. Two families with nonsyndromic low-frequency hearing loss harbor novel mutations in Wolfram syndrome gene 1. J Mol Med 2005
62. Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, Watanabe Y, Shinoda K, Oka Y. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 2001;10:477-484
63. Hofmann S, Philbrook C, Gerbitz KD, Bauer MF. Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 2003;12:2003-2012
64. Osman AA, Saito M, Makepeace C, Permutt MA, Schlesinger P, Mueckler M. Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J Biol Chem 2003;278:52755-52762
65. Hardy C, Khanim F, Torres R, Scott-Brown M, Seller A, Poulton J, Collier D, Kirk J, Polymeropoulos M, Latif F, Barrett T. Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet 1999;65:1279-1290
66. Furlong RA, Ho LW, Rubinsztein JS, Michael A, Walsh C, Paykel ES, Rubinsztein DC. A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases. Neurosci Lett 1999;277:123-126
67. Ohtsuki T, Ishiguro H, Yoshikawa T, Arinami T. WFS1 gene mutation search in depressive patients: detection of five missense polymorphisms but no association with depression or bipolar affective disorder. J Affect Disord 2000;58:11-17
68. Sam W, Qin H, Crawford B, Yue D, Yu S. Homozygosity for a 4-bp deletion in a patient with Wolfram syndrome suggesting possible phenotype and genotype correlation. Clin Genet 2001;59:136-138
69. Tessa A, Carbone I, Matteoli MC, Bruno C, Patrono C, Patera IP, De Luca F, Lorini R, Santorelli FM. Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum Mutat 2001;17:348-349
70. Torres R, Leroy E, Hu X, Katrivanou A, Gourzis P, Papachatzopoulou A, Athanassiadou A, Beratis S, Collier D, Polymeropoulos MH. Mutation screening of the Wolfram syndrome gene in psychiatric patients. Mol Psychiatry 2001;6:39-43
71. Kadayifci A, Kepekci Y, Coskun Y, Huang Y. Wolfram syndrome in a family with variable expression. Acta Medica (Hradec Kralove) 2001;44:115-118
72. Crawford J, Zielinski MA, Fisher LJ, Sutherland GR, Goldney RD. Is there a relationship between Wolfram syndrome carrier status and suicide? Am J Med Genet 2002;114:343-346
73. Domenech E, Gomez-Zaera M, Nunes V. WFS1 mutations in Spanish patients with diabetes mellitus and deafness. Eur J Hum Genet 2002;10:421-426
74. Komatsu K, Nakamura N, Ghadami M, Matsumoto N, Kishino T, Ohta T, Niikawa N, Yoshiura K. Confirmation of genetic homogeneity of nonsyndromic low-frequency sensorineural hearing loss by linkage analysis and a DFNA6/14 mutation in a Japanese family. J Hum Genet 2002;47:395-399
75. Kunz J, Marquez-Klaka B, Uebe S, Volz-Peters A, Berger R, Rausch P. Identification of a novel mutation in WFS1 in a family affected by low-frequency hearing impairment. Mutat Res 2003;525:121-124
76. Giuliano F, Bannwarth S, Monnot S, Cano A, Chabrol B, Vialettes B, Delobel B, Paquis-Fluckinger V. Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum Mutat 2005;25:99-100
77. Swift M, Swift RG. Wolframin mutations and hospitalization for psychiatric illness. Mol Psychiatry 2005
78. Domenech E, Kruyer H, Gomez C, Calvo MT, Nunes V. First prenatal diagnosis for Wolfram syndrome by molecular analysis of the WFS1 gene. Prenat Diagn 2004;24:787-789
79. van den Ouweland JM, Cryns K, Pennings RJ, Walraven I, Janssen GM, Maassen JA, Veldhuijzen BF, Arntzenius AB, Lindhout D, Cremers CW, Van Camp G, Dikkeschei LD. Molecular characterization of WFS1 in patients with Wolfram syndrome. J Mol Diagn 2003;5:88-95
80. Awata T, Inoue K, Kurihara S, Ohkubo T, Inoue I, Abe T, Takino W, Kanazawa Y, Katayama S. Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis. Biochem Biophys Res Commun 2000;268:612-616
81. Evans KL, Lawson D, Meitinger T, Blackwood DH, Porteous DJ. Mutational analysis of the Wolfram syndrome gene in two families with chromosome 4p-linked bipolar affective disorder. Am J Med Genet 2000;96:158-160
82. Middle F, Jones I, McCandless F, Barrett T, Khanim F, Owen MJ, Lendon C, Craddock N. Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the Wolfram gene. Am J Med Genet 2000;96:154-157
83. Martorell L, Zaera MG, Valero J, Serrano D, Figuera L, Joven J, Labad A, Vilella E, Nunes V. The WFS1 (Wolfram syndrome 1) is not a major susceptibility gene for the development of psychiatric disorders. Psychiatr Genet 2003;13:29-32
84. Koto T, Iwamoto K, Washizulca S, Mori K, Tajima O, Akiyama T, Nanko S, Kunuji H, Kato N. No association of mutations and mRNA expression of WFS1/wolframin with bipolar disorder in humans. Neurosci Lett 2003;338:21-24
85. Swift M, Swift RG. Psychiatric disorders and mutations at the Wolfram syndrome locus. Biol Psychiatry 2000;47:787-793
86. Gunter TE, Yule DI, Gunter KK, Eliseev KA, Salter JD. Calcium and mitochondria. FEBS Letters 2004;567:92-102